Artivion, Inc. Logo

Artivion, Inc.

CRY

(0.5)
Stock Price

17,88 USD

-2.19% ROA

-0.29% ROE

-128.14x PER

Market Cap.

1.076.662.950,00 USD

107.6% DER

0% Yield

-0.22% NPM

Artivion, Inc. Stock Analysis

Artivion, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Artivion, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (2.06x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

2 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (221), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

3 ROE

Negative ROE (-8.78%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-4.89%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 DER

The stock is burdened with a heavy load of debt (131%), making it financially unstable and potentially risky for investors.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Artivion, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Artivion, Inc. Technical Stock Analysis
# Analysis Recommendation

Artivion, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Artivion, Inc. Revenue
Year Revenue Growth
1991 15.300.000
1992 19.600.000 21.94%
1993 21.200.000 7.55%
1994 23.600.000 10.17%
1995 29.000.000 18.62%
1996 37.000.000 21.62%
1997 50.900.000 27.31%
1998 60.700.000 16.14%
1999 66.722.000 9.03%
2000 77.096.000 13.46%
2001 87.671.000 12.06%
2002 77.795.000 -12.69%
2003 59.532.000 -30.68%
2004 62.384.000 4.57%
2005 69.282.000 9.96%
2006 81.311.000 14.79%
2007 94.763.000 14.2%
2008 105.059.000 9.8%
2009 111.685.000 5.93%
2010 116.645.000 4.25%
2011 119.626.000 2.49%
2012 131.718.000 9.18%
2013 140.763.000 6.43%
2014 144.641.000 2.68%
2015 145.898.000 0.86%
2016 180.380.000 19.12%
2017 189.702.000 4.91%
2018 262.841.000 27.83%
2019 276.222.000 4.84%
2020 253.227.000 -9.08%
2021 298.836.000 15.26%
2022 313.789.000 4.77%
2023 351.416.000 10.71%
2023 354.004.000 0.73%
2024 392.076.000 9.71%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Artivion, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 2.600.000 100%
1996 2.800.000 7.14%
1997 3.900.000 28.21%
1998 4.700.000 17.02%
1999 4.396.000 -6.92%
2000 5.207.000 15.58%
2001 4.737.000 -9.92%
2002 4.597.000 -3.05%
2003 3.644.000 -26.15%
2004 3.938.000 7.47%
2005 3.724.000 -5.75%
2006 3.547.000 -4.99%
2007 4.453.000 20.35%
2008 5.309.000 16.12%
2009 5.247.000 -1.18%
2010 5.923.000 11.41%
2011 6.899.000 14.15%
2012 7.257.000 4.93%
2013 8.454.000 14.16%
2014 8.699.000 2.82%
2015 10.436.000 16.64%
2016 13.446.000 22.39%
2017 19.461.000 30.91%
2018 23.098.000 15.75%
2019 22.960.000 -0.6%
2020 24.207.000 5.15%
2021 35.546.000 31.9%
2022 38.879.000 8.57%
2023 25.684.000 -51.37%
2023 28.707.000 10.53%
2024 29.988.000 4.27%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Artivion, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 65.149.000 100%
2013 68.112.000 4.35%
2014 73.754.000 7.65%
2015 74.929.000 1.57%
2016 91.548.000 18.15%
2017 101.211.000 9.55%
2018 140.574.000 28%
2019 143.011.000 1.7%
2020 140.036.000 -2.12%
2021 168.774.000 17.03%
2022 155.843.000 -8.3%
2023 0 0%
2023 168.583.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Artivion, Inc. EBITDA
Year EBITDA Growth
1991 -200.000
1992 1.800.000 111.11%
1993 1.400.000 -28.57%
1994 2.300.000 39.13%
1995 3.800.000 39.47%
1996 7.100.000 46.48%
1997 11.400.000 37.72%
1998 7.700.000 -48.05%
1999 12.748.000 39.6%
2000 12.864.000 0.9%
2001 17.920.000 28.21%
2002 -32.870.000 154.52%
2003 -23.705.000 -38.66%
2004 -16.323.000 -45.22%
2005 -14.994.000 -8.86%
2006 1.542.000 1072.37%
2007 13.335.000 88.44%
2008 13.799.000 3.36%
2009 18.835.000 26.74%
2010 13.404.000 -40.52%
2011 11.657.000 -14.99%
2012 12.571.000 7.27%
2013 13.850.000 9.23%
2014 14.376.000 3.66%
2015 4.463.000 -222.12%
2016 13.540.000 67.04%
2017 8.442.000 -60.39%
2018 9.397.000 10.16%
2019 16.530.000 43.15%
2020 -476.000 3572.69%
2021 10.114.000 104.71%
2022 25.682.000 60.62%
2023 11.772.000 -118.16%
2023 37.864.000 68.91%
2024 56.604.000 33.11%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Artivion, Inc. Gross Profit
Year Gross Profit Growth
1991 8.200.000
1992 10.800.000 24.07%
1993 13.100.000 17.56%
1994 15.600.000 16.03%
1995 19.500.000 20%
1996 25.800.000 24.42%
1997 35.800.000 27.93%
1998 38.900.000 7.97%
1999 39.706.000 2.03%
2000 46.971.000 15.47%
2001 51.042.000 7.98%
2002 12.162.000 -319.68%
2003 28.050.000 56.64%
2004 24.759.000 -13.29%
2005 36.860.000 32.83%
2006 43.890.000 16.02%
2007 59.222.000 25.89%
2008 67.794.000 12.64%
2009 69.768.000 2.83%
2010 68.368.000 -2.05%
2011 75.844.000 9.86%
2012 85.018.000 10.79%
2013 90.386.000 5.94%
2014 91.291.000 0.99%
2015 90.719.000 -0.63%
2016 118.899.000 23.7%
2017 128.642.000 7.57%
2018 172.984.000 25.63%
2019 183.013.000 5.48%
2020 167.784.000 -9.08%
2021 197.514.000 15.05%
2022 202.523.000 2.47%
2023 225.080.000 10.02%
2023 213.978.000 -5.19%
2024 237.476.000 9.89%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Artivion, Inc. Net Profit
Year Net Profit Growth
1991 -700.000
1992 700.000 200%
1993 600.000 -16.67%
1994 1.300.000 53.85%
1995 2.200.000 40.91%
1996 3.900.000 43.59%
1997 4.700.000 17.02%
1998 6.500.000 27.69%
1999 4.451.000 -46.03%
2000 7.817.000 43.06%
2001 9.166.000 14.72%
2002 -27.761.000 133.02%
2003 -32.294.000 14.04%
2004 -18.749.000 -72.24%
2005 -19.535.000 4.02%
2006 365.000 5452.05%
2007 7.201.000 94.93%
2008 32.908.000 78.12%
2009 8.679.000 -279.17%
2010 3.944.000 -120.06%
2011 7.371.000 46.49%
2012 7.946.000 7.24%
2013 16.172.000 50.87%
2014 7.322.000 -120.87%
2015 4.005.000 -82.82%
2016 10.778.000 62.84%
2017 3.704.000 -190.98%
2018 -3.805.000 197.35%
2019 1.720.000 321.22%
2020 -16.682.000 110.31%
2021 -14.834.000 -12.46%
2022 -19.192.000 22.71%
2023 -39.204.000 51.05%
2023 -30.567.000 -28.26%
2024 -8.468.000 -260.97%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Artivion, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1991 0
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 -1 100%
2003 -2 0%
2004 -1 0%
2005 -1 0%
2006 0 0%
2007 0 0%
2008 1 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 -1 0%
2023 -1 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Artivion, Inc. Free Cashflow
Year Free Cashflow Growth
1991 -2.900.000
1992 -700.000 -314.29%
1993 -2.800.000 75%
1994 1.200.000 333.33%
1995 -500.000 340%
1996 -5.200.000 90.38%
1997 -7.300.000 28.77%
1998 -5.500.000 -32.73%
1999 -2.866.000 -91.91%
2000 788.000 463.71%
2001 -7.850.000 110.04%
2002 -6.211.000 -26.39%
2003 -6.887.000 9.82%
2004 -17.176.000 59.9%
2005 -19.506.000 11.95%
2006 -2.713.000 -618.98%
2007 8.085.000 133.56%
2008 7.799.000 -3.67%
2009 14.882.000 47.59%
2010 13.305.000 -11.85%
2011 14.213.000 6.39%
2012 15.920.000 10.72%
2013 12.434.000 -28.04%
2014 2.798.000 -344.39%
2015 7.339.000 61.87%
2016 12.295.000 40.31%
2017 3.762.000 -226.82%
2018 4.095.000 8.13%
2019 7.755.000 47.2%
2020 5.041.000 -53.84%
2021 -15.676.000 132.16%
2022 -15.868.000 1.21%
2023 5.758.000 375.58%
2023 11.146.000 48.34%
2024 3.622.000 -207.73%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Artivion, Inc. Operating Cashflow
Year Operating Cashflow Growth
1991 -2.300.000
1992 0 0%
1993 -2.000.000 100%
1994 2.600.000 176.92%
1995 1.100.000 -136.36%
1996 4.000.000 72.5%
1997 -2.200.000 281.82%
1998 1.200.000 283.33%
1999 987.000 -21.58%
2000 10.279.000 90.4%
2001 6.479.000 -58.65%
2002 -2.111.000 406.92%
2003 -5.932.000 64.41%
2004 -16.226.000 63.44%
2005 -18.517.000 12.37%
2006 -1.071.000 -1628.94%
2007 9.292.000 111.53%
2008 9.537.000 2.57%
2009 16.572.000 42.45%
2010 20.837.000 20.47%
2011 16.751.000 -24.39%
2012 18.990.000 11.79%
2013 16.772.000 -13.22%
2014 8.118.000 -106.6%
2015 11.442.000 29.05%
2016 19.719.000 41.97%
2017 10.803.000 -82.53%
2018 9.881.000 -9.33%
2019 15.827.000 37.57%
2020 12.369.000 -27.96%
2021 -2.585.000 578.49%
2022 -5.153.000 49.84%
2023 7.232.000 171.25%
2023 18.576.000 61.07%
2024 6.135.000 -202.79%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Artivion, Inc. Capital Expenditure
Year Capital Expenditure Growth
1991 600.000
1992 700.000 14.29%
1993 800.000 12.5%
1994 1.400.000 42.86%
1995 1.600.000 12.5%
1996 9.200.000 82.61%
1997 5.100.000 -80.39%
1998 6.700.000 23.88%
1999 3.853.000 -73.89%
2000 9.491.000 59.4%
2001 14.329.000 33.76%
2002 4.100.000 -249.49%
2003 955.000 -329.32%
2004 950.000 -0.53%
2005 989.000 3.94%
2006 1.642.000 39.77%
2007 1.207.000 -36.04%
2008 1.738.000 30.55%
2009 1.690.000 -2.84%
2010 7.532.000 77.56%
2011 2.538.000 -196.77%
2012 3.070.000 17.33%
2013 4.338.000 29.23%
2014 5.320.000 18.46%
2015 4.103.000 -29.66%
2016 7.424.000 44.73%
2017 7.041.000 -5.44%
2018 5.786.000 -21.69%
2019 8.072.000 28.32%
2020 7.328.000 -10.15%
2021 13.091.000 44.02%
2022 10.715.000 -22.17%
2023 1.474.000 -626.93%
2023 7.430.000 80.16%
2024 2.513.000 -195.66%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Artivion, Inc. Equity
Year Equity Growth
1991 6.600.000
1992 7.300.000 9.59%
1993 16.600.000 56.02%
1994 17.900.000 7.26%
1995 20.500.000 12.68%
1996 24.900.000 17.67%
1997 30.200.000 17.55%
1998 80.400.000 62.44%
1999 80.226.000 -0.22%
2000 89.395.000 10.26%
2001 101.439.000 11.87%
2002 79.800.000 -27.12%
2003 48.338.000 -65.09%
2004 49.660.000 2.66%
2005 50.621.000 1.9%
2006 52.088.000 2.82%
2007 62.627.000 16.83%
2008 99.326.000 36.95%
2009 110.446.000 10.07%
2010 -113.942.000 196.93%
2011 121.538.000 193.75%
2012 128.112.000 5.13%
2013 144.747.000 11.49%
2014 148.685.000 2.65%
2015 155.251.000 4.23%
2016 208.983.000 25.71%
2017 279.035.000 25.11%
2018 275.067.000 -1.44%
2019 285.696.000 3.72%
2020 328.713.000 13.09%
2021 300.728.000 -9.31%
2022 284.329.000 -5.77%
2023 271.975.000 -4.54%
2023 281.780.000 3.48%
2024 295.056.000 4.5%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Artivion, Inc. Assets
Year Assets Growth
1991 10.900.000
1992 12.400.000 12.1%
1993 20.100.000 38.31%
1994 21.400.000 6.07%
1995 23.600.000 9.32%
1996 35.000.000 32.57%
1997 53.700.000 34.82%
1998 98.400.000 45.43%
1999 94.025.000 -4.65%
2000 112.009.000 16.06%
2001 129.310.000 13.38%
2002 106.414.000 -21.52%
2003 75.027.000 -41.83%
2004 73.261.000 -2.41%
2005 76.809.000 4.62%
2006 79.865.000 3.83%
2007 92.684.000 13.83%
2008 125.995.000 26.44%
2009 133.859.000 5.87%
2010 137.438.000 2.6%
2011 147.864.000 7.05%
2012 157.156.000 5.91%
2013 174.683.000 10.03%
2014 176.157.000 0.84%
2015 181.179.000 2.77%
2016 316.140.000 42.69%
2017 591.670.000 46.57%
2018 571.091.000 -3.6%
2019 605.654.000 5.71%
2020 789.404.000 23.28%
2021 793.052.000 0.46%
2022 762.798.000 -3.97%
2023 774.787.000 1.55%
2023 792.397.000 2.22%
2024 789.539.000 -0.36%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Artivion, Inc. Liabilities
Year Liabilities Growth
1991 4.300.000
1992 5.100.000 15.69%
1993 3.500.000 -45.71%
1994 3.500.000 0%
1995 3.100.000 -12.9%
1996 10.100.000 69.31%
1997 23.500.000 57.02%
1998 18.000.000 -30.56%
1999 13.799.000 -30.44%
2000 22.614.000 38.98%
2001 27.871.000 18.86%
2002 26.614.000 -4.72%
2003 26.689.000 0.28%
2004 23.601.000 -13.08%
2005 26.188.000 9.88%
2006 27.777.000 5.72%
2007 30.057.000 7.59%
2008 26.669.000 -12.7%
2009 23.413.000 -13.91%
2010 251.380.000 90.69%
2011 26.326.000 -854.87%
2012 29.044.000 9.36%
2013 29.936.000 2.98%
2014 27.472.000 -8.97%
2015 25.928.000 -5.95%
2016 107.157.000 75.8%
2017 312.635.000 65.72%
2018 296.024.000 -5.61%
2019 319.958.000 7.48%
2020 460.691.000 30.55%
2021 492.324.000 6.43%
2022 478.469.000 -2.9%
2023 502.812.000 4.84%
2023 510.617.000 1.53%
2024 494.483.000 -3.26%

Artivion, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
9.04
Net Income per Share
-0.2
Price to Earning Ratio
-128.14x
Price To Sales Ratio
2.86x
POCF Ratio
126.55
PFCF Ratio
-1015.72
Price to Book Ratio
3.63
EV to Sales
3.67
EV Over EBITDA
26.89
EV to Operating CashFlow
163.53
EV to FreeCashFlow
-1305.92
Earnings Yield
-0.01
FreeCashFlow Yield
-0
Market Cap
1,08 Bil.
Enterprise Value
1,38 Bil.
Graham Number
5.65
Graham NetNet
-8.15

Income Statement Metrics

Net Income per Share
-0.2
Income Quality
-1.01
ROE
-0.03
Return On Assets
-0
Return On Capital Employed
0.06
Net Income per EBT
-0.1
EBT Per Ebit
0.21
Ebit per Revenue
0.11
Effective Tax Rate
1.1

Margins

Sales, General, & Administrative to Revenue
0.26
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.62
Operating Profit Margin
0.11
Pretax Profit Margin
0.02
Net Profit Margin
-0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.2
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
1.13
Capex to Revenue
0.03
Capex to Depreciation
0.41
Return on Invested Capital
-1.41
Return on Tangible Assets
-0.02
Days Sales Outstanding
76.45
Days Payables Outstanding
30.33
Days of Inventory on Hand
208.93
Receivables Turnover
4.77
Payables Turnover
12.04
Inventory Turnover
1.75
Capex per Share
0.23

Balance Sheet

Cash per Share
1,32
Book Value per Share
7,08
Tangible Book Value per Share
-2.72
Shareholders Equity per Share
7.08
Interest Debt per Share
8.31
Debt to Equity
1.08
Debt to Assets
0.4
Net Debt to EBITDA
5.97
Current Ratio
4.63
Tangible Asset Value
-0,11 Bil.
Net Current Asset Value
-0,26 Bil.
Invested Capital
671221000
Working Capital
0,18 Bil.
Intangibles to Total Assets
0.52
Average Receivables
0,08 Bil.
Average Payables
0,01 Bil.
Average Inventory
81259000
Debt to Market Cap
0.29

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Artivion, Inc. Dividends
Year Dividends Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%

Artivion, Inc. Profile

About Artivion, Inc.

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

CEO
Mr. James Mackin
Employee
1.200
Address
1655 Roberts Blvd NW
Kennesaw, 30144

Artivion, Inc. Executives & BODs

Artivion, Inc. Executives & BODs
# Name Age

Artivion, Inc. Competitors